NordicStockExchange.aiData, not trading
Menu
← Nordic companies
SE
Rank 94 · Nasdaq Stockholm

Getinge

GETI-B.ST · LEI 5493003PZ4F570G3W735

AI-readable JSON ↗
Market-value snapshotUSD 6.58bn
Map typeCompany-specific strategic
Strategic drivers6
VerificationAnalyst hypothesis
Geostrategic analyst layer

Transmission map

As of 2026-09-12

Getinge is analysed through its specific exposure to intensive-care, surgical-workflow and life-science equipment. Getinge benefits from healthcare demand and demographics but faces reimbursement, product regulation, supply and currency risks.

mixedcompany specific

Hospital capital spending and product-quality execution

ICU and operating-room investment drives Getinge orders, while quality remediation and consumables determine margin and risk.

Watch
Acute Care Therapies orders and quality costs · latest company guidance
Offsets
installed base and recurring consumables
high materiality · high confidence · immediate to years
benefitdemand

Healthcare, hygiene and consumer staples demand — Getinge

For Getinge's intensive-care, surgical-workflow and life-science equipment, demographics, infection control and essential consumption support resilient volumes.

Watch
Acute Care Therapies orders and quality costs · hospital volumes · retail sell-through · demographics
Offsets
private-label competition · procurement pressure
high materiality · medium confidence · months to years
mixedregulation

Medical-device approval and reimbursement — Getinge

For Getinge's intensive-care, surgical-workflow and life-science equipment, product approvals, quality systems and reimbursement determine market access, launch timing and compliance cost.

Watch
Acute Care Therapies orders and quality costs · regulatory approvals · recalls · reimbursement decisions
Offsets
portfolio breadth · quality controls
high materiality · medium confidence · months to years
harmsupply chain

Critical components and logistics continuity — Getinge

For Getinge's intensive-care, surgical-workflow and life-science equipment, shortages, supplier failures or transport delays can stop production and defer high-value deliveries.

Watch
Acute Care Therapies orders and quality costs · lead times · inventory days · delivery delays
Offsets
dual sourcing · safety stock · redesign
high materiality · medium confidence · months to years
harmregulation

Medicine pricing and payer intervention — Getinge

For Getinge's intensive-care, surgical-workflow and life-science equipment, price negotiation, rebates or formulary restrictions can reduce realised prices and eligible patient access.

Watch
Acute Care Therapies orders and quality costs · payer decisions · gross-to-net trends · reference pricing
Offsets
volume growth · new indications · geographic diversity
high materiality · medium confidence · months to years
mixedgeofinance

Currency translation and transaction exposure — Getinge

For Getinge's intensive-care, surgical-workflow and life-science equipment, exchange-rate moves change translated sales, imported costs and price competitiveness across markets.

Watch
Acute Care Therapies orders and quality costs · major currency pairs · constant-currency growth · hedge disclosures
Offsets
natural hedges · financial hedging
high materiality · medium confidence · months to years

Reference reports

Matched news context

Last 48 hours

No qualifying company matches from news published in the last 48 hours.